D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 370 KRW -4.88% Market Closed
Market Cap: 719.7B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Dongkook Pharmaceutical Co Ltd

Revenue
764.7B KRW
Cost of Revenue
-337B KRW
Gross Profit
427.6B KRW
Operating Expenses
-352.8B KRW
Operating Income
74.9B KRW
Other Expenses
-20.4B KRW
Net Income
54.5B KRW

Income Statement
Dongkook Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
220 612
N/A
224 391
+2%
226 014
+1%
228 198
+1%
234 687
+3%
244 766
+4%
259 930
+6%
275 174
+6%
292 760
+6%
302 007
+3%
309 690
+3%
320 349
+3%
330 629
+3%
342 293
+4%
354 768
+4%
366 905
+3%
378 387
+3%
391 800
+4%
400 807
+2%
418 583
+4%
436 293
+4%
456 230
+5%
482 280
+6%
502 390
+4%
520 469
+4%
544 685
+5%
559 103
+3%
572 390
+2%
588 359
+3%
585 740
0%
594 193
+1%
615 974
+4%
631 065
+2%
645 744
+2%
661 647
+2%
676 772
+2%
692 794
+2%
709 543
+2%
730 994
+3%
747 013
+2%
764 673
+2%
Gross Profit
Cost of Revenue
(94 329)
(95 575)
(98 041)
(99 097)
(102 533)
(105 870)
(111 578)
(115 214)
(120 762)
(124 611)
(126 781)
(132 120)
(136 043)
(139 273)
(145 412)
(151 522)
(155 139)
(160 383)
(162 858)
(169 097)
(175 871)
(183 440)
(191 445)
(198 389)
(205 265)
(213 813)
(221 694)
(227 674)
(236 998)
(240 243)
(243 933)
(256 244)
(264 210)
(270 754)
(281 822)
(291 152)
(300 870)
(310 064)
(320 213)
(327 915)
(337 031)
Gross Profit
126 283
N/A
128 816
+2%
127 974
-1%
129 100
+1%
132 153
+2%
138 895
+5%
148 352
+7%
159 959
+8%
171 997
+8%
177 395
+3%
182 909
+3%
188 229
+3%
194 585
+3%
203 019
+4%
209 356
+3%
215 382
+3%
223 248
+4%
231 417
+4%
237 949
+3%
249 486
+5%
260 422
+4%
272 789
+5%
290 835
+7%
304 000
+5%
315 203
+4%
330 872
+5%
337 410
+2%
344 717
+2%
351 362
+2%
345 497
-2%
350 260
+1%
359 730
+3%
366 856
+2%
374 990
+2%
379 826
+1%
385 620
+2%
391 925
+2%
399 479
+2%
410 781
+3%
419 099
+2%
427 641
+2%
Operating Income
Operating Expenses
(99 869)
(102 084)
(101 419)
(103 360)
(106 595)
(110 589)
(114 742)
(122 305)
(127 942)
(132 136)
(135 983)
(140 092)
(148 179)
(155 887)
(159 285)
(163 740)
(168 995)
(173 386)
(182 834)
(192 595)
(201 971)
(212 383)
(222 250)
(230 591)
(238 519)
(247 048)
(252 676)
(259 708)
(268 824)
(276 682)
(287 041)
(292 709)
(295 660)
(303 468)
(307 172)
(317 064)
(330 422)
(335 645)
(343 908)
(350 521)
(352 750)
Selling, General & Administrative
(89 512)
(92 040)
(91 193)
(92 722)
(95 877)
(99 947)
(104 265)
(111 161)
(117 152)
(121 475)
(125 188)
(130 082)
(137 271)
(143 713)
(145 976)
(148 815)
(152 719)
(157 349)
(165 834)
(174 923)
(182 535)
(190 249)
(199 245)
(207 045)
(215 523)
(224 472)
(230 420)
(237 354)
(245 591)
(249 859)
(258 083)
(261 987)
(263 937)
(273 431)
(279 435)
(289 111)
(301 649)
(306 898)
(312 714)
(317 656)
(318 860)
Research & Development
(9 702)
(9 407)
(9 621)
(10 089)
(10 161)
(10 178)
(10 099)
(10 801)
(10 470)
(10 312)
(10 415)
(9 621)
(10 500)
(11 730)
(12 788)
(14 287)
(15 531)
(15 186)
(15 960)
(16 044)
(17 273)
(19 407)
(19 890)
(20 445)
(19 883)
(19 468)
(18 859)
(18 877)
(19 590)
(22 519)
(24 691)
(26 376)
(27 156)
(25 748)
(23 105)
(23 036)
(23 600)
(23 514)
(25 456)
(26 786)
(27 439)
Depreciation & Amortization
(656)
(638)
(606)
(549)
(557)
(463)
(379)
(344)
(322)
(352)
(380)
(393)
(412)
(448)
(522)
(642)
(749)
(854)
(1 040)
(1 630)
(2 165)
(2 729)
(3 115)
(3 104)
(3 115)
(3 111)
(3 398)
(3 509)
(3 665)
(4 329)
(4 266)
(4 346)
(4 567)
(4 288)
(4 632)
(4 917)
(5 173)
(5 233)
(5 738)
(6 078)
(6 452)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
3
0
4
4
4
0
4
4
3
0
0
0
0
0
3
0
3
0
32
23
25
0
0
0
0
0
0
0
0
0
0
0
Operating Income
26 413
N/A
26 730
+1%
26 554
-1%
25 739
-3%
25 557
-1%
28 305
+11%
33 610
+19%
37 653
+12%
44 054
+17%
45 259
+3%
46 926
+4%
48 137
+3%
46 406
-4%
47 132
+2%
50 071
+6%
51 642
+3%
54 253
+5%
58 031
+7%
55 115
-5%
56 890
+3%
58 450
+3%
60 405
+3%
68 585
+14%
73 409
+7%
76 684
+4%
83 824
+9%
84 734
+1%
85 009
+0%
82 539
-3%
68 815
-17%
63 219
-8%
67 021
+6%
71 195
+6%
71 522
+0%
72 654
+2%
68 556
-6%
61 503
-10%
63 834
+4%
66 873
+5%
68 578
+3%
74 891
+9%
Pre-Tax Income
Interest Income Expense
1 918
1 153
1 389
1 339
2 058
1 744
1 742
1 641
1 257
3 252
5 814
4 558
5 102
3 573
952
2 585
3 325
2 971
6 868
6 887
6 601
8 097
5 120
7 087
6 361
5 155
(446)
(2 007)
(2 916)
(1 844)
7 744
5 447
4 819
5 431
(3 776)
(1 793)
(1 568)
(2 471)
(4 939)
(1 132)
(2 155)
Non-Reccuring Items
(442)
(431)
(389)
(387)
(112)
(111)
(13)
(11)
(11)
(11)
(11)
(12)
(12)
(12)
(11)
(12)
(12)
(12)
(11)
(189)
(189)
(189)
(11)
165
165
165
(11)
(12)
0
0
0
0
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
42
53
57
26
22
11
11
(4)
15
15
22
0
0
8
331
436
539
506
432
327
244
276
(341)
(338)
(369)
(365)
(2)
(77)
(68)
(70)
966
1 630
1 659
1 656
619
26
(1)
751
753
753
849
Total Other Income
1 281
1 313
800
875
925
721
1 441
1 483
1 530
1 588
1 382
1 234
1 243
1 100
1 448
1 248
1 067
654
703
1 012
1 556
2 381
2 276
2 243
880
176
(4 243)
(4 723)
(4 673)
(3 816)
(2 176)
(2 494)
(2 349)
(2 793)
(864)
(427)
(615)
(2 021)
(1 850)
(2 685)
(2 350)
Pre-Tax Income
29 212
N/A
28 818
-1%
28 412
-1%
27 591
-3%
28 450
+3%
30 670
+8%
36 791
+20%
40 763
+11%
46 845
+15%
50 103
+7%
54 133
+8%
53 917
0%
52 739
-2%
51 801
-2%
52 790
+2%
55 901
+6%
59 172
+6%
62 150
+5%
63 107
+2%
64 927
+3%
66 663
+3%
70 970
+6%
75 629
+7%
82 566
+9%
83 722
+1%
88 957
+6%
80 031
-10%
78 190
-2%
74 882
-4%
63 086
-16%
69 754
+11%
71 605
+3%
75 324
+5%
75 816
+1%
68 632
-9%
66 361
-3%
59 319
-11%
60 093
+1%
60 838
+1%
65 514
+8%
71 235
+9%
Net Income
Tax Provision
(10 621)
(10 880)
(7 415)
(6 930)
(7 036)
(7 618)
(9 564)
(10 387)
(11 745)
(12 036)
(13 440)
(13 480)
(12 848)
(12 697)
(11 923)
(12 511)
(13 478)
(14 242)
(13 674)
(13 054)
(13 586)
(14 507)
(16 579)
(19 544)
(19 556)
(22 768)
(22 150)
(22 008)
(21 509)
(19 209)
(16 837)
(18 309)
(17 130)
(14 009)
(13 876)
(11 292)
(10 133)
(10 397)
(11 966)
(12 779)
(15 933)
Income from Continuing Operations
18 591
17 938
20 997
20 661
21 414
23 052
27 227
30 376
35 100
38 068
40 693
40 438
39 891
39 103
40 868
43 389
45 695
47 909
49 433
51 874
53 077
56 463
59 050
63 022
64 166
66 188
57 880
56 181
53 372
43 878
52 916
53 296
58 194
61 808
54 757
55 069
49 186
49 696
48 871
52 734
55 302
Income to Minority Interest
268
168
102
149
(34)
87
199
113
92
34
(33)
(15)
107
(1 032)
(1 266)
(1 695)
(2 824)
(2 215)
(2 484)
(2 717)
(2 459)
(2 666)
(2 738)
(2 662)
(2 596)
(2 686)
(1 955)
(1 665)
(888)
67
(2 571)
(2 376)
(2 583)
(2 864)
(1 861)
(1 839)
(2 029)
(2 222)
(1 696)
(1 910)
(810)
Net Income (Common)
18 859
N/A
18 106
-4%
21 098
+17%
20 810
-1%
21 379
+3%
23 139
+8%
27 426
+19%
30 488
+11%
35 192
+15%
38 100
+8%
40 660
+7%
40 421
-1%
39 996
-1%
38 070
-5%
39 602
+4%
41 695
+5%
42 872
+3%
45 695
+7%
46 949
+3%
49 157
+5%
50 618
+3%
53 797
+6%
56 312
+5%
60 360
+7%
61 569
+2%
63 501
+3%
55 925
-12%
54 515
-3%
52 484
-4%
43 945
-16%
50 345
+15%
50 919
+1%
55 611
+9%
58 943
+6%
52 896
-10%
53 230
+1%
47 157
-11%
47 474
+1%
47 175
-1%
50 824
+8%
54 492
+7%
EPS (Diluted)
428.61
N/A
411.5
-4%
479.5
+17%
472.95
-1%
485.88
+3%
525.88
+8%
623.31
+19%
692.9
+11%
799.81
+15%
865.9
+8%
924.09
+7%
918.65
-1%
909
-1%
865.22
-5%
900.04
+4%
947.61
+5%
974.36
+3%
1 038.52
+7%
1 067.02
+3%
1 092.37
+2%
1 124.84
+3%
1 195.48
+6%
1 251.37
+5%
1 341.33
+7%
1 368.2
+2%
1 411.13
+3%
1 242.77
-12%
1 211.44
-3%
1 173.64
-3%
982.69
-16%
1 125.82
+15%
1 138.65
+1%
1 243.39
+9%
1 317.88
+6%
1 182.73
-10%
1 190.15
+1%
1 054.2
-11%
1 061.28
+1%
1 054.64
-1%
1 136.17
+8%
1 218
+7%

See Also

Discover More